Propranolol suppresses HUVEC viability, migration, VEGF expression, and promotes apoptosis by downregulation of miR-4295

High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5

(2018) Qinggong Yuan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway

(2017) Dongfan Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

PM2.5 exposure decreases viability, migration and angiogenesis in human umbilical vein endothelial cells and human microvascular endothelial cells

(2017) Shengguang Chen et al.   Molecular Medicine Reports

RUNX3 is down-regulated in glioma by Myc-regulated miR-4295

(2016) Xinxing Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis

(2016) S. Chinnadurai et al.   PEDIATRICS

miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A

(2015) Mingchen Shao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth

(2015) Lei Zhang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Vincristine for Successful Treatment of Steroid-Dependent Infantile Hemangiomas

(2015) J. D. Wasserman et al.   PEDIATRICS

Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation

(2015) Naikhoba C.O. Munabi et al.   Stem Cells Translational Medicine

FOXF1 Transcription Factor Is Required for Formation of Embryonic Vasculature by Regulating VEGF Signaling in Endothelial Cells

(2014) Xiaomeng Ren et al.   CIRCULATION RESEARCH

Fox(y) Regulators of VEGF Receptors

(2014) Nicolas Ricard et al.   CIRCULATION RESEARCH

A further experience of propranolol for severe infantile hemangiomas of the face: an observational study

(2014) Antonella Greco et al.   Dermatologic Therapy

Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

(2012) B. A. Drolet et al.   PEDIATRICS

Basic and Therapeutic Aspects of Angiogenesis

(2011) Michael Potente et al.   CELL

Infantile haemangiomas: a challenge in paediatric dermatology

(2010) RA Schwartz et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center

(2010) Lisa M. Buckmiller et al.   LARYNGOSCOPE

Signaling mechanisms in infantile hemangioma

(2009) Eileen Boye et al.   CURRENT OPINION IN HEMATOLOGY

Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma

(2009) Françoise Denoyelle et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

(2009) V. Sans et al.   PEDIATRICS

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma

(2008) Masatoshi Jinnin et al.   NATURE MEDICINE

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE